| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/22/2005 | CN1628661A Enteric-coated quick releasing formulation of tannic acid and total matrine for treating enteritis |
| 06/22/2005 | CN1628660A Externally used liquid preparation containing fibrauretine and its application on genital tract, oral cavity and upper respiratory tract |
| 06/22/2005 | CN1628659A Aromatase inhibitor |
| 06/22/2005 | CN1628658A Mitiglinide/metformin hydrochloride oral compound antihypelipidemic preparation and preparation method thereof |
| 06/22/2005 | CN1628657A 茴三硫软胶囊及其制备方法 Anetholtrithione soft capsule and its preparation method |
| 06/22/2005 | CN1628656A Armillarisin A soft capsule and preparation method thereof |
| 06/22/2005 | CN1628655A Andrographolide dispersed tablet and preparation method thereof |
| 06/22/2005 | CN1628654A Liver benefiting effective agent prepared from hepadestal and preparation method thereof |
| 06/22/2005 | CN1628653A Medicine for trichomonas vaginalis disease |
| 06/22/2005 | CN1628652A Method for treating palmar fascia and plantar aponeurosis fibromatosis |
| 06/22/2005 | CN1628651A Alcohol effect relieving refreshment liver protecting preparation |
| 06/22/2005 | CN1628650A Compound diisopropylamine dichloroacetate freeze dried injection and preparation method thereof |
| 06/22/2005 | CN1628649A Pharmaceutical combination containing red sage root element and preparation method thereof |
| 06/22/2005 | CN1628648A Loxoprofen sodium sustained release preparation |
| 06/22/2005 | CN1628647A 盐酸氨溴索颗粒剂 Ambroxol Hydrochloride Granules |
| 06/22/2005 | CN1628646A Dispersed tablet of tartaric acid tolterodine tartrate |
| 06/22/2005 | CN1628645A Ambroxol hydrochloride oral disintegrating tablet and preparation method thereof |
| 06/22/2005 | CN1628644A Medicine for recurrent baby pig bowel oedema disease and preparation method thereof |
| 06/22/2005 | CN1628638A Liposome preparation containing Oxaliplatin |
| 06/22/2005 | CN1628520A Externally used preparation for household pet disinsection and sterilization |
| 06/22/2005 | CN1207308C Ganoderma applanatum polysaccharide, its preparation and medicine composition using said compound as active component |
| 06/22/2005 | CN1207302C Method and compounds for curing diseases caused by mutations |
| 06/22/2005 | CN1207297C Crystalline therapeutic agent |
| 06/22/2005 | CN1207296C Farnesyl transferase inhibiting 1, 2-annelated quinoline enantiomer |
| 06/22/2005 | CN1207295C Method for preparing pyrazo-(4, 3-d) pyrimidine-7-ketone and its intermediate |
| 06/22/2005 | CN1207294C Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 06/22/2005 | CN1207290C 2, 4-disubstituted triazine derivatives |
| 06/22/2005 | CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 06/22/2005 | CN1207288C Retroviral protease inhibiting compounds |
| 06/22/2005 | CN1207283C 4-aminopiperidine derivatives and their use as medicine |
| 06/22/2005 | CN1207268C Novel derivatives of 3-3-diphenylpropylamines |
| 06/22/2005 | CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors |
| 06/22/2005 | CN1207048C Product for regulating blood-lipid and protecting liver and preparation process thereof |
| 06/22/2005 | CN1207040C Externally applied pharmaceutical composition for treating skin disease and venereal disease |
| 06/22/2005 | CN1207038C Chinese medicinal composition for removing speckles and its preparing method |
| 06/22/2005 | CN1207019C Multifunctional paster |
| 06/22/2005 | CN1207016C Burn and scald treating oil |
| 06/22/2005 | CN1207008C Acne ointment and its preparing process |
| 06/22/2005 | CN1207002C Antineoplastic composite and its prepn process and use |
| 06/22/2005 | CN1207001C Gentiamarin powder infection for muscle injection and intravenous injection |
| 06/22/2005 | CN1207000C :Roxoithromycin suppostory and its prepn. |
| 06/22/2005 | CN1206999C Spreader cong. compound Triamcinolone acetate, and its prepn. method |
| 06/22/2005 | CN1206998C Composition and method for treating penile erectile dysfunction |
| 06/22/2005 | CN1206997C Endothelin antagonist |
| 06/22/2005 | CN1206996C Pharmaceutical composition for treating or preventing sleep disorders |
| 06/22/2005 | CN1206995C Anti beta-bactamase antibiotic compound prepn. |
| 06/22/2005 | CN1206994C Medicinal complsition containing vitamin B 1, preparation process and use thereof |
| 06/22/2005 | CN1206993C Buspirong hydrochloride transdemal absorption preparation |
| 06/22/2005 | CN1206992C Rifapentine or Rifampicin microemulsion and suspension perfusate and injection and their preparation |
| 06/22/2005 | CN1206991C Preparation containing Cetirizine Hydrochloride and hydrochloric pseudoephedrine and its prepn. method |
| 06/22/2005 | CN1206990C Liquid preparation containing norfloxacin and metronidazole |
| 06/22/2005 | CN1206989C Mixed snuff prepn. for reducing side effect of Apomorphinum |
| 06/22/2005 | CN1206988C Eye gel for atropine sulfate |
| 06/22/2005 | CN1206987C Indomethacin liposome eye drops |
| 06/22/2005 | CN1206986C Coated trimebutine maleate tablet |
| 06/22/2005 | CN1206985C Soluble L-calcium lactate preparation and preparing method |
| 06/22/2005 | CN1206984C Pellets having a core coated with an antifungal and a polymer |
| 06/22/2005 | CN1206983C Coated Hypericum perforatus extract micro pill preparation and its preparing process |
| 06/22/2005 | CN1206978C Anti-caries oral compositions |
| 06/22/2005 | CN1206976C Compositions and method for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| 06/22/2005 | CN1206921C Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the N-hydroxy anilide-type |
| 06/21/2005 | WO2005066180A1 Cysteine protease inhibitors |
| 06/21/2005 | US6909014 Intermediates for the synthesis of ether compounds |
| 06/21/2005 | US6909007 Steroidal pharmaceutical compounds |
| 06/21/2005 | US6909002 Nitrogen compounds such as N-Cyclopropyl-1-(3-(6-(1-hydroxy-1 -methylethyl)-1-oxidopryidin-3-yl)phenyl)-4-oxo-1,4-dihydro-1, 8-naphthyridine-3-carboxyamide, formed condensation and amidation in the presence of catalysts; drugs |
| 06/21/2005 | US6909000 Inhibiting particularly the activity of hepatitis C virus NS3-NS4A protease; peptidomimetics having a bridged bicyclic moiety at the P2 position. |
| 06/21/2005 | US6908999 Process for the preparation of {2-[4-α-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxy} acetic acid and novel intermediates therefor |
| 06/21/2005 | US6908948 Saturated nitrogen compounds, that bind to nucleic acids and generate chemical intermediates that splice the strands; prophylaxis of tumors and viral diseases |
| 06/21/2005 | US6908946 Conjugated nonadecadienoic acid compositions |
| 06/21/2005 | US6908944 Using 1-phenyl-4-(dimethylaminomethyl)cyclohexane |
| 06/21/2005 | US6908943 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/21/2005 | US6908942 Carbocyclic oxy amines such as 2,2-dimethyl-3-(4-fluorobenzyl) ether-4-methoxy-6-(4-methoxybenzyl)amino Benzopyran and libraries, used for prophylaxis of eating disorders induced by lipid peroxidation; antioxidants |
| 06/21/2005 | US6908940 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 06/21/2005 | US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 06/21/2005 | US6908937 Heterocyclic fluoroalkenyl thioethers (II) |
| 06/21/2005 | US6908936 Respiratory syncytial virus |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/21/2005 | US6908934 Therapeutic compounds for treating dyslipidemic conditions |
| 06/21/2005 | US6908931 1-(2,2-diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline- 2-carbaldehyde; for treating sleep disorders |
| 06/21/2005 | US6908930 4-substituted 7-AZA-indolin-2-ones and their use as protein kinase inhibitors |
| 06/21/2005 | US6908929 Central nervous system disorders |
| 06/21/2005 | US6908927 Reduction physical cigarette smoking |
| 06/21/2005 | US6908926 Substituted imidazoles, their preparation and use |
| 06/21/2005 | US6908925 Administering to a candidate subject in need of such treatment, a thus-effective amount of at least one inhibitor of at least one calcium channel for loosening/slackening and/or relaxing cutaneous and/or subcutaneous human skin |
| 06/21/2005 | US6908924 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections |
| 06/21/2005 | US6908923 Compositions and methods for treating heart failure |
| 06/21/2005 | US6908922 Linear cyclic ureas |
| 06/21/2005 | US6908920 Pyrimidine derivatives |
| 06/21/2005 | US6908918 Ketone spirocyclopropaneindene compounds; antineoplastic agents to inhibit tumor cell growth in vitro or in vivo; particularly effective against solid tumors and multi-drug resistant tumors |
| 06/21/2005 | US6908917 Chromone derivatives as matrix metalloproteinase inhibitors |
| 06/21/2005 | US6908916 C-5 modified indazolylpyrrolotriazines |
| 06/21/2005 | US6908914 Antipsychotic cyclic N-aralkylamines |
| 06/21/2005 | US6908912 For controlling free-living microorganisms/biofilm growth |
| 06/21/2005 | US6908910 Antiproliferative agent; wound healing agents; antiinflammatory agents |
| 06/21/2005 | US6908909 Liquid oral compositions comprising a calcium compound and an acidulant |
| 06/21/2005 | US6908906 Crystalline forms of pyrimidine nucleoside derivative |
| 06/21/2005 | US6908904 Pharmaceutical preparation and method for treatment of diabetes |
| 06/21/2005 | US6908902 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| 06/21/2005 | US6908783 Method of doping organic semiconductors with quinonediimine derivatives |
| 06/21/2005 | US6908733 Diagnosis and treatment of human kidney diseases |